Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Preferred Shares (2016 - 2021)

Historic Preferred Shares for Cardiff Oncology (CRDF) over the last 11 years, with Q4 2021 value amounting to $1000.0.

  • Cardiff Oncology's Preferred Shares changed 0.0% to $1000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $1000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $1000.0 for FY2021, which is 0.0% changed from last year.
  • Latest data reveals that Cardiff Oncology reported Preferred Shares of $1000.0 as of Q4 2021, which was down 0.0% from $1000.0 recorded in Q3 2021.
  • In the past 5 years, Cardiff Oncology's Preferred Shares registered a high of $1000.0 during Q4 2020, and its lowest value of $60.0 during Q1 2017.
  • Over the past 5 years, Cardiff Oncology's median Preferred Shares value was $60.0 (recorded in 2017), while the average stood at $391.9.
  • Within the past 5 years, the most significant YoY rise in Cardiff Oncology's Preferred Shares was 156666.67% (2020), while the steepest drop was 7692.31% (2020).
  • Quarter analysis of 5 years shows Cardiff Oncology's Preferred Shares stood at $60.0 in 2017, then changed by 0.0% to $60.0 in 2018, then changed by 0.0% to $60.0 in 2019, then soared by 1566.67% to $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2021.
  • Its last three reported values are $1000.0 in Q4 2021, $1000.0 for Q3 2021, and $1000.0 during Q2 2021.